These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12794567)

  • 41. Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN).
    Pogány K; van Valkengoed IG; Prins JM; Nieuwkerk PT; van der Ende I; Kauffmann RH; Kroon FP; Verbon A; Nievaard MF; Lange JM; Brinkman K
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):395-400. PubMed ID: 17195761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali.
    Merci NM; Emerence U; Augustin N; Habtu M; Julie I; Angelique T; Jessica B; Cynthia A; Penda AT
    Pan Afr Med J; 2017; 26():14. PubMed ID: 28450993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function.
    Jacobson MA; Khayam-Bashi H; Martin JN; Black D; Ng V
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):472-7. PubMed ID: 12473834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune reconstitution after highly active anti-retroviral treatment of HIV infection.
    Autran B; Carcelain G; Debre P
    Adv Exp Med Biol; 2001; 495():205-12. PubMed ID: 11774568
    [No Abstract]   [Full Text] [Related]  

  • 45. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
    Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
    Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
    East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [HIV infection: in the HAART era, CD4 makes the difference].
    Varsky C
    Acta Gastroenterol Latinoam; 2004; 34(3):117-9. PubMed ID: 15742925
    [No Abstract]   [Full Text] [Related]  

  • 49. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART.
    Massanella M; Negredo E; Pérez-Alvarez N; Puig J; Ruiz-Hernández R; Bofill M; Clotet B; Blanco J
    AIDS; 2010 Apr; 24(7):959-68. PubMed ID: 20177358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of HIV-1 and CD4+ T cell dynamic parameters in patients treated with genotypic resistance testing-guided HAART.
    Cappuccio A; Castiglione F; Piccoli B; Tozzi V
    Curr HIV Res; 2008 Jun; 6(4):363-9. PubMed ID: 18691034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
    Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
    J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
    Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
    J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.
    Katlama C; Carcelain G; Duvivier C; Chouquet C; Tubiana R; De Sa M; Zagury L; Calvez V; Autran B; Costagliola D;
    AIDS; 2002 Oct; 16(15):2027-34. PubMed ID: 12370501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A complex system of chemokines may hold the key to optimal CD4+ T-cell recovery after antiretroviral therapy.
    Sun YV; Marconi VC
    EBioMedicine; 2020 Dec; 62():103113. PubMed ID: 33181464
    [No Abstract]   [Full Text] [Related]  

  • 59. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.
    Romiti ML; Cancrini C; Castelli-Gattinara G; Di Cesare S; Ciaffi P; Bernardi S; De Gasperi MR; Halapi E; Rossi P
    AIDS; 2001 Nov; 15(16):2075-84. PubMed ID: 11684926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poorer immunologic outcome on treatment among patients infected with HIV-1 non-B subtypes compared with subtype B in Singapore.
    Lee LK; Lin L; Chua A; Leo YS; Ng OT
    Clin Infect Dis; 2012 Jun; 54(12):1818-20. PubMed ID: 22423124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.